These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 6989198)

  • 1. Release of prostacyclin into the bloodstream in humans after local blood flow changes.
    Serneri GC; Masotti G; Poggesi L; Galanti G
    Adv Prostaglandin Thromboxane Res; 1980; 7():715-8. PubMed ID: 6989198
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostacyclin release induced by bradykinin may contribute to the antihypertensive action of angiotensin-converting enzyme inhibitors.
    Mullane KM; Moncada S; Vane JR
    Adv Prostaglandin Thromboxane Res; 1980; 7():1159-61. PubMed ID: 6245567
    [No Abstract]   [Full Text] [Related]  

  • 3. Release of prostacyclin into the bloodstream and its exhaustion in humans after local blood flow changes (ischemia and venous stasis).
    Serneri GG; Masotti G; Poggesi L; Galanti G
    Thromb Res; 1980 Jan 1-15; 17(1-2):197-208. PubMed ID: 6990547
    [No Abstract]   [Full Text] [Related]  

  • 4. Release of a prostacyclin-like substance into the circulation of dogs by intravenous adenosine 5'-diphosphate.
    Hemker DP; Shebuski RJ; Aiken JW
    J Pharmacol Exp Ther; 1980 Feb; 212(2):246-52. PubMed ID: 6985960
    [No Abstract]   [Full Text] [Related]  

  • 5. Platelet microaggregates and release of endogenous prostacyclin during the initial phase of haemodialysis.
    Leithner C; Sinzinger H; Silberbauer K; Stummvoll HK
    Proc Eur Dial Transplant Assoc; 1981; 18():122-5. PubMed ID: 7036146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of prostacyclin in human plasma and whole blood: studies on the protective effect of albumin.
    Orchard MA; Robinson C
    Thromb Haemost; 1981 Oct; 46(3):645-7. PubMed ID: 7031983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The prostaglandin-prostacyclin system and thrombocyte functions in patients with systemic lupus erythematosus].
    Pribytkov IuN; Poltyrev AS; Shilkina NP
    Ter Arkh; 1992; 64(12):44-8. PubMed ID: 1292132
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostacyclin-release by bradykinin in vivo [proceedings].
    Moncada S; Mullane KM; Vane JR
    Br J Pharmacol; 1979 May; 66(1):96P-97P. PubMed ID: 378310
    [No Abstract]   [Full Text] [Related]  

  • 9. Prostacyclin is produced in whole blood [proceedings].
    Blackwell GJ; Flower RJ; Russell-Smith N; Salmon JA; Thorogood PB; Vane JR
    Br J Pharmacol; 1978 Nov; 64(3):436P. PubMed ID: 363208
    [No Abstract]   [Full Text] [Related]  

  • 10. Peripheral vasodilator effects of prostaglandins: comparison of 6-keto-prostaglandin E1 with prostacyclin and escape from prostaglandin E2 in the mesenteric vascular bed.
    Feigen LP; Chapnick BM; Hyman AL; King L; Marascalco B; Kadowitz PJ
    J Pharmacol Exp Ther; 1980 Sep; 214(3):528-34. PubMed ID: 6995573
    [No Abstract]   [Full Text] [Related]  

  • 11. [High circulating prostacyclin levels in patients with chronic renal insufficiency (author's transl)].
    Carreras LO; Chamone DA; Vermylen J
    Sangre (Barc); 1981; 26(4):427-32. PubMed ID: 7027492
    [No Abstract]   [Full Text] [Related]  

  • 12. [The influence of prostacyclin on gastrointestinal blood flow during hypovolemic shock (author's transl)].
    Jakesz R; Starlinger M; Bratusch-Marrein P; Schiessel R; Schemper M
    Chir Forum Exp Klin Forsch; 1980; ():227-31. PubMed ID: 6993124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Physiological significance of PGI2 (prostacyclin) in fetal circulating blood].
    Matsumoto T; Kihira M; Ito M; Sugiyama Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Nov; 34(11):1919-20. PubMed ID: 6757341
    [No Abstract]   [Full Text] [Related]  

  • 14. Action of prostacyclin (PGI2) and prostaglandin E2 (PGE2) on gastric secretion and mucosal blood flow in dogs.
    Konturek SJ
    Gastroenterology; 1980 Jul; 79(1):182-4. PubMed ID: 6991360
    [No Abstract]   [Full Text] [Related]  

  • 15. Thromboxane, prostacyclin, and hemodynamic events in primate endotoxin shock.
    Fletcher JR; Ramwell PW; Harris RH
    Adv Shock Res; 1981; 5():143-8. PubMed ID: 7030016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An inverse correlation between plasma prostacyclin and serum triglycerides.
    Viinikka L; Ylikorkala O
    N Engl J Med; 1980 Jun; 302(25):1424-5. PubMed ID: 6990259
    [No Abstract]   [Full Text] [Related]  

  • 17. Disappearance of prostacyclin (PGI2) in the circulation of the dog [proceedings].
    Dusting GJ; Moncada S; Vane JR
    Br J Pharmacol; 1978 Mar; 62(3):414P-415P. PubMed ID: 346132
    [No Abstract]   [Full Text] [Related]  

  • 18. Gastric antisecretory and cardiovascular actions of a stable 16-phenoxy prostacyclin analog in the dog.
    Kauffman GL; Whittle BJ; Aures D; Grossman MI
    Adv Prostaglandin Thromboxane Res; 1980; 8():1521-4. PubMed ID: 6990722
    [No Abstract]   [Full Text] [Related]  

  • 19. Prostacyclin release in vivo.
    Dandona P; Mikhailidis DP; Jeremy JY
    Lancet; 1983 Apr; 1(8328):823-4. PubMed ID: 6132160
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of prostacyclin on some hemodynamic parameters in dogs.
    Filczewski M; Oledzka K
    Pol J Pharmacol Pharm; 1981; 33(5):491-8. PubMed ID: 7038645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.